The Neurally platform is a project that creates technology related to Clinical Neurophysiology. Its general objective is the generation of knowledge oriented to the improvement of technologies used for the monitoring and treatment of neurophysiological signals, such as neonatal brain activity monitoring (aEEG), visual, auditory or somatosensory evoked potentials tests, repetitive transcranial magnetic stimulation (rTMS) treatments, polysomnography and continuous monitoring in ICU. The group currently has two patented technologies (aCUP-E and EPlacement) in the process of clinical validation, which are expected to be commercially available in 2026.
